Design and synthesis of theranostic antibiotic nanodrugs that display enhanced antibacterial activity and luminescence.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 28743748.
- Also identified by DOI 10.1073/pnas.1708556114 and PMC identifier 5559051.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We report the modular formulation of ciprofloxacin-based pure theranostic nanodrugs that display enhanced antibacterial activities, as well as aggregation-induced emission (AIE) enhancement that was successfully used to image bacteria. The drug derivatives, consisting of ciprofloxacin, a perfluoroaryl ring, and a phenyl ring linked by an amidine bond, were efficiently synthesized by a straightforward protocol from a perfluoroaryl azide, ciprofloxacin, and an aldehyde in acetone at room temperature. These compounds are propeller-shaped, and upon precipitation into water, readily assembled into stable nanoaggregates that transformed ciprofloxacin derivatives into AIE-active luminogens. The nanoaggregates displayed increased luminescence and were successfully used to image bacteria. In addition, these nanodrugs showed enhanced antibacterial activities, lowering the minimum inhibitory concentration (MIC) by more than one order of magnitude against both sensitive and resistant <i>Escherichia coli</i> The study represents a strategy in the design and development of pure theranostic nanodrugs for combating drug-resistant bacterial infections.
Medical subject headings
- Ciprofloxacin